GoodRx Holdings, Inc. (GDRX) financial statements and ratios from SEC XBRL: revenue $796.85M (TTM), net margin 3.8%, revenue growth 0.6% YoY, P/E 104.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $796.85M |
| Net Margin | 3.8% |
| Revenue Growth (YoY) | 0.6% |
| EPS Growth (YoY) | 125.0% |
| FCF Growth (YoY) | -10.0% |
| P/E Ratio | 104.2 |
| EV / EBITDA | 9.4 |
| Price / Book | 1.93 |
| Price / Sales | 1.59 |
| FCF Yield | 19.6% |
| DCF Value (model) | $0.35 |
| DCF Upside vs Price | -90.3% |
| Altman Z-Score | 0.68 (distress) |
| Sector P/E (Technology) | 33.9 |
GDRX overview · GDRX earnings · GDRX KPIs · GDRX investor relations · GDRX ownership · GDRX peers · GDRX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.